RxDoctor Payments Data

Mary Kaiser, NP

Adult Health · Kalamazoo, MINPI 1144242371

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (36.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Organogenesis Inc. accounts for 89.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $5,623 and has fallen 87.0% since, to $733 in 2025. Among adult health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,094in general payments, 2019–2025

Across 94 payments — averaging $128.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$11K
  • Smith+Nephew$637
  • Tactile Systems Technology Inc$219
  • Medela LLC$75
  • Solventum Corporation$66
  • Mimedx Group, Inc.$47
  • plus $192 from 8 others

What the payments were for

  • Consulting fees$4,37536%
  • Speaking & faculty fees$3,70031%
  • Travel & lodging$5354%
  • Food & beverage$3,46429%
  • Education$200%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,094 in reported general payments places this provider in the 95th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Medicare billing

Part B allowed, 2024
$23,676
Medicare patients
71
Services billed
433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$173

Paid to pharmacies, not to this prescriber.

Other adult health in Kalamazoo

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →